In particular, Rho-kinase inhibitors exhibited anti-psychotic-like effects not only in Arhgap10 S490P/NHEJ mice but also in pharmacologic models of schizophrenia (methamphetamine- and MK-801-treated mice). This evidence concerns the gene ARHGAP10 and schizophrenia.